Essex Bio-Technology (SEHK:1061) Balance Sheet Analysis 2000-2025

Socials

NEWSLETTER

View Data Providers

NEWSLETTER

View Data Providers

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

Metric	2024	2025
Total Cash And Short-Term Investments	HK$560.739M	HK$784.142M
Net Receivables	HK$617.02M	HK$707.625M
Inventory	HK$58.938M	HK$79.398M
Prepaid Expenses And Other Current Assets	HK$44.669M	-
Other Current Assets	HK$1.935M	HK$48.96M
Total Current Assets	HK$1.283B	HK$1.62B
Property, Plant And Equipment	HK$414.206M	HK$517.129M
Goodwill And Intangible Assets	HK$0.939B	HK$1.323B
Long-Term Investments	HK$46.973M	HK$14.943M
Deferred Tax Assets	-	-
Other Noncurrent Assets	HK$299.622M	HK$15.835M
Total Noncurrent Assets	HK$1.7B	HK$1.871B
Other Assets	-	-
Total Assets	HK$2.983B	HK$3.491B

Metric	2024	2025
Total Payables	HK$7.359M	HK$138.056M
Accrued Expenses	HK$402.399M	-
Short-Term Debt	HK$69.798M	HK$69.101M
Current Portion Of Lease Obligations	HK$3.265M	-
Income Taxes Payable	HK$90.518M	-
Current Deferred Revenue	-	-
Other Current Liabilities	HK$226.156M	HK$559.748M
Total Current Liabilities	HK$708.978M	HK$766.905M
Long-Term Debt	HK$77.124M	HK$243.48M
Capital Lease Obligations	HK$21.691M	HK$17.162M
Noncurrent Deferred Revenue	-	-
Noncurrent Deferred Tax Liabilities	HK$36.372M	HK$32.966M
Other Noncurrent Liabilities	-	-
Total Noncurrent Liabilities	HK$150.347M	HK$310.77M
Other Liabilities	-	-
Total Liabilities	HK$0.859B	HK$1.078B

Metric	2024	2025
Treasury Stock	-	-
Preferred Stock	-	-
Common Stock	HK$56.713M	HK$56.701M
Retained Earnings	HK$2.217B	-
Additional Paid-In Capital	HK$73.278M	-
Accumulated Other Comprehensive Income	HK$-223.005M	-
Other Stockholders' Equity	-	HK$2.356B
Total Common Stockholders' Equity	HK$2.124B	HK$2.413B
Minority Interest	-	-
Total Equity	HK$2.124B	HK$2.413B
Total Liabilities And Equity	HK$2.983B	HK$3.491B

Metric	2024	2025
Total Investments	HK$50.545M	HK$16.355M
Total Debt	HK$187.039M	HK$346.904M
Net Debt	HK$-370.128M	HK$-435.826M

Essex Bio-Technology Balance Sheet

Balance Sheet Composition